Ticker > Company >

Cryogenic OGS share price

Cryogenic OGS Ltd.

BSE: 544440 SECTOR: Engineering - Industrial Equipments  1.89 K   7   0

143.00
-5.80 (-3.90%)
BSE: 18 Sep 04:01 PM

Price Summary

Today's High

₹ 150.4

Today's Low

₹ 142.75

52 Week High

₹ 165.5

52 Week Low

₹ 89.3

FinStar

Ownership Stable
Ownership strength is slightly missing the benchmark.
ValuationAttractive
The stock is considerably attractive based on intrinsic value.
EfficiencyExcellent
The company knows very well the utilization of its assets.
FinancialsVery Stable
The company possesses stable growth history and manageable debt.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

204.2 Cr.

Enterprise Value

193.14 Cr.

No. of Shares

1.43 Cr.

P/E

33.35

P/B

4.37

Face Value

₹ 10

Div. Yield

0 %

Book Value (TTM)

₹  32.74

CASH

11.07 Cr.

DEBT

0 Cr.

Promoter Holding

73.53 %

EPS (TTM)

₹  4.29

Sales Growth

35.67%

ROE

23.62 %

ROCE

32.12%

Profit Growth

14.55 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year35.67%
3 Year12.15%
5 YearNA

Profit Growth

1 Year14.55%
3 Year23.11%
5 YearNA

ROE%

1 Year23.62%
3 Year25.47%

ROCE %

1 Year32.12%
3 Year34.26%

Debt/Equity

0

Price to Cash Flow

105.5

Interest Cover Ratio

139.2592

CFO/PAT (5 Yr. Avg.)

0

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Jul 2025 73.53 0.00
Jun 2025 73.53 0.00
Investors List
* Figures given above are % of equity capital

 Strengths

  • Company has been maintaining healthy ROE of 25.4742666666667% over the past 3 years.
  • Company has been maintaining healthy ROCE of 34.2590333333333% over the past 3 years.
  • Company is virtually debt free.
  • Company has a healthy Interest coverage ratio of 139.2592.
  • The company has an efficient Cash Conversion Cycle of 50.2501 days.
  • Company has a healthy liquidity position with current ratio of 5.2584.
  • The company has a high promoter holding of 73.53%.
  • Promoter stake has increased from 0% to 73.53% in the last 1 quarter.

 Limitations

  • The company has shown a poor revenue growth of 12.1450548897464% for the Past 3 years.
  • The company has a low EBITDA margin of 0% over the past 5 years.

Quarterly Result (All Figures in Cr.)

 Quarterly Data is not available for this company.Report us

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2022 Mar 2023 Mar 2024 Mar 2025
Net Sales 23.33 22.02 24.25 32.9
Total Expenditure 18.98 16.37 17.87 24.94
Operating Profit 4.35 5.65 6.39 7.96
Other Income 0.67 0.69 1.42 0.89
Interest 0.1 0.18 0.12 0.06
Depreciation 0.49 0.68 0.57 0.52
Exceptional Items 0 0 0 0
Profit Before Tax 4.43 5.48 7.12 8.27
Tax 1.15 1.4 1.78 2.15
Net Profit 3.28 4.08 5.35 6.12
Adjusted EPS (Rs.) 3.13 3.88 5.09 5.83

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity and Liabilities
Share Capital 0.5 0.5 0.5 10.5
Total Reserves 12.94 17.02 22.36 18.49
Borrowings 0 0 0 0
Other N/C liabilities 0.16 0.16 -0.02 0.14
Current liabilities 8.8 6.27 5.22 4.61
Total Liabilities 22.4 23.95 28.07 33.73
Assets
Net Block 7.69 7.36 6.88 6.61
Capital WIP 0 0.05 0 0
Intangible WIP 0 0 0 0
Investments 0.91 1.2 2.16 2.46
Loans & Advances 0.24 0.08 0.11 0.44
Other N/C Assets 0 0 0 0
Current Assets 13.56 15.26 18.91 24.22
Total Assets 22.4 23.95 28.07 33.73
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2022 Mar 2023 Mar 2024 Mar 2025
Profit from operations 4.43 5.48 7.12 8.27
Adjustment -0.08 0.17 -0.36 0.39
Changes in Assets & Liabilities -0.55 -2.65 -3.44 -4.44
Tax Paid -1.33 -1.16 -1.8 -2.29
Operating Cash Flow 2.47 1.84 1.53 1.94
Investing Cash Flow -0.81 -0.08 -1.33 -1.36
Financing Cash Flow -0.78 -1.74 -0.12 -0.06
Net Cash Flow 0.88 0.01 0.08 0.51

Corporate Actions

Investors Details

 No Promoters Data available for this company.Report us
 No Investors Data available for this company.Report us

Annual Reports

Title Link
Title Link
 No Annual reports exist for this company.Report us

Ratings & Research Reports

TYPE AGENCY Link
TYPE AGENCY Link
 No Credit and Research reports exist for this company.Report us
TYPE AGENCY Link
TYPE AGENCY Link
 No Research reports exist for this company.Report us

Concalls & Presentations

TYPE QUARTER Link
TYPE QUARTER Link
 Currently we do not have any Presentation and Concall related to this company.Report us
TYPE QUARTER Link
TYPE QUARTER Link
 Currently we do not have any Presentation related to this company.Report us

Company News

Cryogenic OGS Stock Price Analysis and Quick Research Report. Is Cryogenic OGS an attractive stock to invest in?

Stock investing requires careful analysis of financial data to determine a company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement, which can be time-consuming and cumbersome.

Examining a company's financial ratios is an easier way to determine its performance, which can help to make sense of the overwhelming amount of information in its financial statements. 

Here are a few indispensable ratios that should be a part of every investor’s research process, or, in simpler words, how to analyse Cryogenic OGS. 

  • PE ratio: Price to Earnings ratio, which indicates how much an investor is willing to pay for a share for every rupee of earnings. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). Cryogenic OGS has a PE ratio of 33.3527696793003 which is high and comparatively overvalued.

  • Return on Assets (ROA): Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Cryogenic OGS has ROA of 19.815% which is a good sign for future performance. (Higher values are always desirable.)

  • Current ratio: The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Cryogenic OGS has a Current ratio of 5.2584.

  • Return on equity: ROE measures the ability of a firm to generate profits from its shareholders' investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Cryogenic OGS has a ROE of 23.6169%. (Higher is better)

  • Debt to equity ratio: It is a good metric to check out the capital structure along with its performance. Cryogenic OGS has a Debt to Equity ratio of 0 which means that the company has low proportion of debt in its capital.

  • Sales growth: Cryogenic OGS has reported revenue growth of 35.6661% which is fair in relation to its growth and performance. 

  • Operating Margin: This will tell you about the operational efficiency of the company. The operating margin of Cryogenic OGS for the current financial year is 24.1954012508889%.

  • Dividend Yield: It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Cryogenic OGS is Rs 0 and the yield is 0%.

  • Earnings Per Share: It tells us how much profit is allocated to to each outstanding share of a common stock. The latest EPS of Cryogenic OGS is Rs 4.2875. The higher the EPS, the better it is for investors. 

One can find all the Financial Ratios of Cryogenic OGS in Ticker for free. Also, one can get the intrinsic value of Cryogenic OGS by using Valuation Calculators, which are available with a Finology ONE subscription. 

Cryogenic OGS FAQs

Q1. What is Cryogenic OGS share price today?
Ans: The current share price of Cryogenic OGS is Rs 143.

Q2. What is the market capitalisation of Cryogenic OGS?
Ans: Cryogenic OGS has a market capitalisation of Rs 204.204 Cr., calculated based on its latest share price.

Q3. What are the P/E and P/B ratios of Cryogenic OGS?
Ans: The PE ratio of Cryogenic OGS is 33.3527696793003 and the P/B ratio of Cryogenic OGS is 4.36781258113288, showing how the stock is valued against its earnings and book value.

Q4. What is the 52-week high and low of Cryogenic OGS share?
Ans: The 52-week high share price of Cryogenic OGS is Rs 165.5, and the 52-week low share price of Cryogenic OGS is Rs 89.3.

Q5. Does Cryogenic OGS pay dividends?
Ans: Currently, Cryogenic OGS does not pay dividends. Dividend yield of Cryogenic OGS is around 0%.

Q6. What are the face value and book value of Cryogenic OGS shares?
Ans: The face value of Cryogenic OGS shares is Rs 10, while the book value per share of Cryogenic OGS is around Rs 32.7395. Face value is the nominal value set by the company, whereas book value reflects its accounting worth.

Q7. What is the debt of Cryogenic OGS?
Ans: Cryogenic OGS has a total debt of Rs 0 Cr., which affects investor sentiment and financial stability. 

Q8. What are the ROE and ROCE of Cryogenic OGS?
Ans: The ROE of Cryogenic OGS is 23.6169% and ROCE of Cryogenic OGS is 32.1226%. ROE shows how efficiently the company is generating profit from shareholders’ equity, while the ROCE is reflects how efficiently the company uses its capital to generate returns.

Q9. Is Cryogenic OGS a good buy for the long term?
Ans: The Cryogenic OGS long-term outlook depends on debt levels, earnings growth, and sector trends. If it sustains profits and manages debt well, it may be considered for long-term investment.

Q10. Is Cryogenic OGS undervalued or overvalued?
Ans: Based on valuation ratios like P/E, P/B, and EV/EBITDA, one can analyse whether the Cryogenic OGS appears undervalued or overvalued at current levels. You can check detailed valuation metrics and peer comparisons on Finology Ticker.

Q11. How to check Cryogenic OGS’s financials?
Ans: You can review Cryogenic OGS’s financial statements - including balance sheet, income statement, and quarterly results - on Finology Ticker.

Last Updated on:
Brief about Cryogenic OGS
X